Board of Directors

Craig R. Travis, M.D., Founder and Chairman

In the more than 40 years that Dr. Travis had been a practicing board-certified emergency physician, the six years he spent in Negril Jamaica (1988-1994) ultimately became the most consequential of his life with the need to reconcile the widespread use of cannabis in a highly promiscuous population with the astonishingly low prevalence of HIV. This led him on a scientific venture in collaboration with other researchers to establish that a novel non-psychoactive derivative of tetrahydrocannabinol (THC) effectively increased the thickness of organotypic vaginal tissue suggesting that it may provide a barrier to the acquisition of HIV disease. However, having recognized the potential rejuvenating properties that the compound might have for atrophied vaginal tissue due to the lack of estrogen, he has redirected Immugen’s research effort to its use as a non-hormonal treatment of the genitourinary syndrome of menopause (GSM) for which he was recently awarded a patent (2021).

As an inventor with four patents for the use of synthetic, non-psychoactive derivatives of THC for the treatment and prevention of HIV, he will continue to explore the potential of our lead compounds for their effects to enhance the integrity of mucosal tissue and its defense that will add to our intellectual property portfolio to ensure that our breakthroughs in science and medicine will benefit all stakeholders – investors and patients alike.

David Fater, CPA - Chief Financial Officer

David Fater, Chief Financial Officer has recruited a dynamic group of individuals with broad scientific and organizational backgrounds to take Immugen forward.

Harold "Hal" Haines, Ph.D

Dr. Haines has 45 years of executive managerial and consulting experience in the healthcare industry, with a broad background in
pharmaceuticals, diagnostics, medical devices and therapeutics.

Wendy J. Weiser - Chief Operating Officer & Board Member

Wendy has expertise in the formation and management of small and large organizations of physicians and scientists. She is also the Founder, CEO and President of the Weiser Group, a company that provides management, consulting, products, education, and business services to healthcare companies and industry. She is also co-founder of a member organization supporting the business needs of Biopharma, medical devices and services companies in the healthcare sectors. Wendy is committed to her clients and affiliates to bring cutting edge solutions for their evolving business needs.

A respected leader in business and association management for over three decades, Wendy is the Founder of WJ Weiser & Associates, Inc. (Company), established in 1988 as a medical practice management firm, which advanced into association management in 1990. At the time of her departure in 2020, the Company was a trusted partner to over 80 leading national and international medical, research and health care related organizations, and became, perhaps, the largest medical association management company in the world, certainly in terms of the numbers of clients. In July of 2015, the Company was sold to private equity.

Wendy began her professional career with Baxter Healthcare Corporation, Physical Therapy Division, where she received numerous promotions with increasing levels of significant responsibilities. At the young age of 25, Wendy was promoted to serve as the Division's Operations Manager, a finance position responsible for designing, overseeing, and controlling the day-to-day business operations and practice management needs for 16 physical therapy centers located throughout the United States, which grew to over 50 centers during her employment. During that time Wendy directed a large and multilayered professional staff efficiently and effectively, and earned high recognition internally and at the corporate headquarters. Baxter launched a new service division based upon the management success of the business practices and policies Wendy established and implemented during her tenure.